Literature DB >> 23996340

Comparison of the efficacy of 4- and 8-week lansoprazole treatment for ESD-induced gastric ulcers: a randomized, prospective, controlled study.

Ji Hoon Park1, Eun Kyung Baek, Chang Hwan Choi, Kyung Hun Lee, Beom Jin Kim, Jeong Wook Kim, Jae Gyu Kim, Sae Kyung Chang.   

Abstract

BACKGROUND: Although endoscopic submucosal dissection (ESD) is widely used to treat gastric neoplasms, there is no consensus for the optimal treatment for ESD-induced ulcers. We compared efficacy between 4 and 8 weeks of lansoprazole treatment for iatrogenic gastric ulcers that developed after ESD.
METHODS: Eighty-four patients who were diagnosed with gastric adenoma or early gastric cancer were enrolled and randomly assigned to treatment with lansoprazole (30 mg/day) for 4 or 8 weeks. Eight weeks after ESD, we conducted follow-up endoscopy to compare ulcer stage and ulcer reduction ratio (dividing the ulcer dimension at 8 weeks by the initial ulcer dimension) between the two groups.
RESULTS: From the 84 patients, 69 patients were included in the final analysis, with 34 in the 4-week group and 35 in the 8-week group. Eight weeks after ESD, there were no significant difference observed between the two groups in terms of the ulcer stage (68 % in the scar stage in the 4-week group vs. 69 % in the 8-week group, P = 0.93) or the ulcer reduction ratio (0.0081 ± 0.015 in the 4-week group vs. 0.0037 ± 0.008 in the 8-week group, P = 0.15). Also, in the subgroup analysis among the patients with large ulcers (>30 mm), those parameters were not different.
CONCLUSIONS: For ESD-induced gastric ulcers, treatment with lansoprazole for 4 weeks was as effective as treatment for 8 weeks. Considering cost-effectiveness, proton pump inhibitor therapy for 4 weeks may be sufficient for ESD-induced gastric ulcers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23996340     DOI: 10.1007/s00464-013-3177-z

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  21 in total

1.  Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials.

Authors:  Zhiping Yang; Qiong Wu; Zhiguo Liu; Kaichun Wu; Daiming Fan
Journal:  Digestion       Date:  2011-11-09       Impact factor: 3.216

2.  Endoscopic mucosal resection for treatment of early gastric cancer.

Authors:  H Ono; H Kondo; T Gotoda; K Shirao; H Yamaguchi; D Saito; K Hosokawa; T Shimoda; S Yoshida
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

3.  Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection-induced ulcers.

Authors:  K Adachi; H Suetsugu; N Moriyama; H Kazumori; A Kawamura; H Fujishiro; H Sato; T Okuyama; S Ishihara; M Watanabe; Y Kinoshita
Journal:  J Gastroenterol Hepatol       Date:  2001-11       Impact factor: 4.029

4.  Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers.

Authors:  Takuji Gotoda; Akio Yanagisawa; Mitsuru Sasako; Hiroyuki Ono; Yukihiro Nakanishi; Tadakazu Shimoda; Yo Kato
Journal:  Gastric Cancer       Date:  2000-12       Impact factor: 7.370

5.  Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.

Authors:  J P Gisbert; L González; X Calvet; M Roqué; R Gabriel; J M Pajares
Journal:  Aliment Pharmacol Ther       Date:  2001-07       Impact factor: 8.171

6.  A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.

Authors:  Y Yamaguchi; N Katsumi; M Tauchi; M Toki; K Nakamura; K Aoki; Y Morita; M Miura; K Morozumi; H Ishida; S Takahashi
Journal:  Aliment Pharmacol Ther       Date:  2005-06       Impact factor: 8.171

7.  Proton pump inhibitor dose-related healing rate of artificial ulcers after endoscopic submucosal dissection: a prospective randomized controlled trial.

Authors:  Seiji Kawano; Hiroyuki Okada; Yoshiro Kawahara; Keisuke Hori; Daisuke Tanioka; Takao Tsuzuki; Masafumi Inoue; Satoru Yagi; Ryuta Takenaka; Kazuhide Yamamoto
Journal:  Digestion       Date:  2011-02-08       Impact factor: 3.216

8.  Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.

Authors:  Perttu Et Arkkila; Kari Seppälä; Timo U Kosunen; Pentti Sipponen; Judit Mäkinen; Hilpi Rautelin; Martti Färkkilä
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-01       Impact factor: 2.566

9.  Evaluation of gastric ulcer healing by lansoprazole by measurement of ulcer diameter.

Authors:  N Aoyama; Y Kinoshita; F Misaki; S Himeno; M Kasuga; T Chiba
Journal:  J Clin Gastroenterol       Date:  1995       Impact factor: 3.062

10.  Degree of healing and healing-associated factors of endoscopic submucosal dissection-induced ulcers after pantoprazole therapy for 4 weeks.

Authors:  Tae-Hoon Oh; Hwoon-Yong Jung; Kee Don Choi; Gin Hyug Lee; Ho June Song; Kwi-Sook Choi; Jun-Won Chung; Jeong-Sik Byeon; Seung-Jae Myung; Suk-Kyun Yang; Jin-Ho Kim
Journal:  Dig Dis Sci       Date:  2008-11-13       Impact factor: 3.199

View more
  4 in total

1.  Effectiveness of Autologous Platelet-Rich Plasma for the Healing of Ulcers after Endoscopic Submucosal Dissection.

Authors:  Eunju Jeong; In Kyung Yoo; Ozlem Ozer Cakir; Hee Kyung Kim; Won Hee Kim; Sung Pyo Hong; Joo Young Cho
Journal:  Clin Endosc       Date:  2019-05-17

Review 2.  Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer.

Authors:  Chan Hyuk Park; Dong-Hoon Yang; Jong Wook Kim; Jie-Hyun Kim; Ji Hyun Kim; Yang Won Min; Si Hyung Lee; Jung Ho Bae; Hyunsoo Chung; Kee Don Choi; Jun Chul Park; Hyuk Lee; Min-Seob Kwak; Bun Kim; Hyun Jung Lee; Hye Seung Lee; Miyoung Choi; Dong-Ah Park; Jong Yeul Lee; Jeong-Sik Byeon; Chan Guk Park; Joo Young Cho; Soo Teik Lee; Hoon Jai Chun
Journal:  Clin Endosc       Date:  2020-03-30

3.  Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers.

Authors:  Da Hyun Jung; Jun Chul Park; Yong Chan Lee; Sang Kil Lee; Sung Kwan Shin; Hyunsoo Chung; Jae Jun Park; Jie-Hyun Kim; Young Hoon Youn; Hyojin Park
Journal:  J Clin Gastroenterol       Date:  2021-03-01       Impact factor: 3.174

4.  Clinical practice guideline for endoscopic resection of early gastrointestinal cancer.

Authors:  Chan Hyuk Park; Dong-Hoon Yang; Jong Wook Kim; Jie-Hyun Kim; Ji Hyun Kim; Yang Won Min; Si Hyung Lee; Jung Ho Bae; Hyunsoo Chung; Kee Don Choi; Jun Chul Park; Hyuk Lee; Min-Seob Kwak; Bun Kim; Hyun Jung Lee; Hye Seung Lee; Miyoung Choi; Dong-Ah Park; Jong Yeul Lee; Jeong-Sik Byeon; Chan Guk Park; Joo Young Cho; Soo Teik Lee; Hoon Jai Chun
Journal:  Intest Res       Date:  2020-10-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.